These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6438641)
1. Adjuvant radiotherapy in Ta, T1 and T2 bladder tumors after transurethral resection--a retrospective study. Rubben H; Lutzeyer W; Ebbinghaus KD; Dahm HH Prog Clin Biol Res; 1984; 162B():21-5. PubMed ID: 6438641 [No Abstract] [Full Text] [Related]
2. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery. Al-Ali MA; Kashmoula DM; Haddad LF Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550 [TBL] [Abstract][Full Text] [Related]
3. Transurethral resection for muscle-invasive bladder cancer. Kondás J; Váczi L; Szecsó L; Kondér G Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277 [TBL] [Abstract][Full Text] [Related]
13. Definitive and adjunctive external irradiation in bladder cancer without radical cystectomy. Pardo De Unceta E; Estecha S; Palomero I Prog Clin Biol Res; 1984; 162B():63-9. PubMed ID: 6438645 [TBL] [Abstract][Full Text] [Related]
14. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT; Yildirim U; Zorlu F; Ozen H J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720 [TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865 [TBL] [Abstract][Full Text] [Related]
17. [Combined therapy for patients with invasive bladder cancer]. Startsev VIu; Karelin MI Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212 [TBL] [Abstract][Full Text] [Related]
18. [Frequency of recurrences and tumor progression on superficial bladder carcinoma (author's transl)]. Rübben H; Dahm HH; Lutzeyer W Urologe A; 1981 Jul; 20(4):211-4. PubMed ID: 7196631 [TBL] [Abstract][Full Text] [Related]
19. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer. Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929 [TBL] [Abstract][Full Text] [Related]
20. [Endoscopic operations in invasive cancer of the urinary bladder]. Martov AG; Chernyshev IV; Sysoev PA; Gushchin BL; Shapovalov VV; Kozlov VV; Kornienko SI Urologiia; 2005; (2):35-9. PubMed ID: 15989025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]